Financials data is unavailable for this security.
View more
Year on year Nipro Corp grew revenues 7.63% from 545.20bn to 586.79bn while net income improved 142.84% from 4.58bn to 11.11bn.
| Gross margin | 29.34% |
|---|---|
| Net profit margin | 0.42% |
| Operating margin | 2.77% |
| Return on assets | 0.23% |
|---|---|
| Return on equity | 0.53% |
| Return on investment | 0.35% |
More ▼
Cash flow in JPYView more
In 2024, Nipro Corp increased its cash reserves by 14.04%, or 11.89bn. The company earned 72.94bn from its operations for a Cash Flow Margin of 12.43%. In addition the company generated 22.14bn cash from financing while 87.08bn was spent on investing.
| Cash flow per share | 381.03 |
|---|---|
| Price/Cash flow per share | 3.56 |
| Book value per share | 1,593.39 |
|---|---|
| Tangible book value per share | 1,361.76 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.42 |
|---|---|
| Quick ratio | 0.7939 |
| Total debt/total equity | 2.56 |
|---|---|
| Total debt/total capital | 0.6908 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 13.64% and 142.87%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 1.97% |
|---|---|
| Div growth rate (5 year) | -2.24% |
| Payout ratio (TTM) | 338.10% |
| EPS growth(5 years) | -1.99 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -90.04 |
More ▼
